Model for end-stage liver disease (MELD) and allocation of donor livers

Russell H. Wiesner, Erick Edwards, Richard B. Freeman, +9

Gastroenterology

Translational MedicineHepatologySolid Organ TransplantationLiver PhysiologyPathology +10

The new liver allocation system: Moving toward evidence-based transplantation policy

Richard B. Freeman, Russell H. Wiesner, Ann Harper, +6

Liver Transplantation

Organ DonationSolid Organ TransplantationPrognosisEvidence-based Transplantation PolicyTransplantation Surgery +18

Results of the first year of the new liver allocation plan

Richard B. Freeman, Russell H. Wiesner, Erick Edwards, +3

Liver Transplantation

Transplantation RatesSolid Organ TransplantationGastroenterologyClinical EpidemiologyGraft Survival +17

Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States

Elizabeth A. Pomfret, Kenneth Washburn, Christoph Wald, +14

Liver Transplantation

Surgical OncologySolid Organ TransplantationSurgeryLiver AllocationUnited States +20

Liver transplantation for hepatocellular carcinoma: The MELD impact

Pratima Sharma, Vijayan Balan, Jose Luis Hernández‐Davó, +8

Liver Transplantation

Solid Organ TransplantationDropout RateHepatobiliary TumorHcc CandidatesRadiation Oncology +14

MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients

Walter K. Kremers, Marrije van IJperen, W. Ray Kim, +4

Hepatology

Disease ProgressionSolid Organ TransplantationPrognosisPosttransplant SurvivalLiver Allocation +17

Optimizing Staging for Hepatocellular Carcinoma Before Liver Transplantation: A Retrospective Analysis of the Unos/Optn Database

Richard B. Freeman, Abigail Mithoefer, Robin Ruthazer, +4

Liver Transplantation

Surgical OncologySolid Organ TransplantationPathologySurgeryOncology +19

Model for end-stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD exception study group and conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula

Richard B. Freeman, Robert G. Gish, Ann Harper, +7

Liver Transplantation

Delayed hepatocellular carcinoma model for end‐stage liver disease exception score improves disparity in access to liver transplant in the United States

Julie K. Heimbach, Ryutaro Hirose, Peter G. Stock, +9

Hepatology

The impact of broader regional sharing of livers: 2‐year results of “Share 35”

Erick B. Edwards, Ann Harper, Ryutaro Hirose, +1

Liver Transplantation

Solid Organ TransplantationTransplantation MedicineTransplantation NetworkOrgan ProcurementPublic Health +22